Priglinger, Siegfried G
3 papers on CoChatORCID 0000-0002-5580-612X
Most cited papers
- Verified
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Heier, J. S., Lad, E. M., Holz, F. G., Rosenfeld, P. J., Guymer, R. H., Boyer, D., Grossi, F., Baumal, C. R., Korobelnik, J.-F., Slakter, J. S., et al. (2023) · The Lancet
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 520
- Verified
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
Pavlou, M., Schön, C., Occelli, L. M., Rossi, A., Meumann, N., Boyd, R. F., Bartoe, J. T., Siedlecki, J., Gerhardt, M. J., Babutzka, S., et al. (2021) · EMBO Molecular Medicine
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 135
- Verified
Assessment of ChatGPT in the preclinical management of ophthalmological emergencies – an analysis of ten fictional case vignettes
Knebel, D., Priglinger, S., Scherer, N., Siedlecki, J., & Schworm, B. (2023) · Klinische Monatsblätter für Augenheilkunde
Artificial Intelligence in Healthcare and EducationOphthalmology and Visual Health Research
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free